SNY

Sanofi ADR

New York Stock Exchange

$52.36

Open: $51.94 High: $52.885 Low: $51.115 Close: $51.24

Range: 2022-01-20 - 2022-01-21

Volume:3,608,418

Market: Closed

Get Free API Key

Download as Excel

SNY

Sanofi ADR 54, Rue La Boétie Paris , 75008 http://www.sanofi.com

Sanofi SA is healthcare company which is engaged in the research, development, manufacture and marketing of therapeutic solutions. It business activities include operations of specialty care, Established Prescription Products and vaccines operations.

CEO: Olivier Brandicourt
Employees: 106,566
Sector: Healthcare
Industry: Drug Manufacturers

Latest Stocks Posts

View All Posts >

SNY News

Latest news about the SNY

Sanofi partners with AI firm Exscientia to develop up to 15 new drugs
French drugmaker Sanofi SA will partner with British AI firm Exscientia Plc to develop up to 15 drug candidates across oncology and immunology, in a deal worth up to $5.2 billion in milestone payments, the two companies said on Friday.
by Reuters at 1/7/22, 6:54 AMView More →
Healthcare group Sanofi forms research deal with the company Exscientia
French healthcare company Sanofi, which has been under pressure to revive its drug pipeline after some setbacks in the COVID-19 vaccine race, announced on Friday a research deal with the company Exscientia to develop new medicines.
by Reuters at 1/7/22, 6:44 AMView More →
French court backs class action against Sanofi over Depakine drug
A French court ruled on Wednesday that families of victims of Depakine, an epilepsy drug that caused birth defects and learning difficulties when taken during pregnancy, could join a class action lawsuit against drugmaker Sanofi.
by Reuters at 1/5/22, 11:59 AMView More →
Sanofi in $1 billion deal to buy U.S.-based Amunix Pharma
Drugmaker Sanofi SA will buy Amunix Pharmaceuticals Inc for an upfront payment of about $1 billion, marking the latest acquisition by the French drugmaker in the U.S. biotech sphere as Sanofi aims to offset COVID-19 vaccine setbacks.
by Reuters at 12/21/21, 6:12 AMView More →
Sanofi (SNY) Q3 2021 Earnings Call Transcript
SNY earnings call for the period ending September 30, 2021.
by The Motley Fool at 10/29/21, 12:00 AMView More →
5 COVID Vaccine Stocks With Late-Stage Candidates You'll Want to Watch
Their vaccines could be late to the party. But the stocks might still be big winners.
by The Motley Fool at 9/18/21, 12:00 AMView More →
KDMN Stock: 6 Things to Know About Biopharma Kadmon Holdings as Shares Skyrocket
Kadmon Holdings (KDMN) stock is rising higher on Wednesday following news of a deal with Sanofi (SNY) that comes to $1.9 billion.
by Investor Place at 9/8/21, 12:00 AMView More →
3 Best Biotech Stocks To Buy for Upcoming Catalysts
The next few months are critical for these biotech stocks which could witness a massive increase in their stock prices this year
by Investor Place at 8/12/21, 12:00 AMView More →
Sanofi (SNY) Q2 2021 Earnings Call Transcript
SNY earnings call for the period ending June 30, 2021.
by The Motley Fool at 7/30/21, 12:00 AMView More →
7 Cheap Value Stocks to Buy for August 2021
These cheap value stocks have the potential to provide shareholders with long-term growth that exceeds their current limiting valuations.
by Investor Place at 7/27/21, 12:00 AMView More →

S&P 500

NASDAQ 100

FTSE 100

QQQ

TESLA

BTC/USD

GBP/USD

GOLD